Kalaris Therapeutics, Inc. (KLRS)

NASDAQ: KLRS · Real-Time Price · USD

9.74

+0.88 (9.93%)

At close: Jan 16, 2026, 4:00 PM EST

9.95

+0.21 (2.16%)

After-hours: Jan 16, 2026, 6:29 PM EST

Kalaris Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Jan '26 Jan 16, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Debt / Equity Ratio	0.04	-0.39	-	-0.61
Quick Ratio	12.70	0.07	0.80	0.54
Current Ratio	12.89	0.11	0.85	0.69
Return on Assets (ROA)	-63.50%	-681.04%	-232.72%	-
Return on Capital Employed (ROCE)	-56.60%	279.00%	2210.80%	781.60%
Buyback Yield / Dilution	-514.28%	-9.18%	-36.56%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q